KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS-mutation and bone metastasis

dc.contributor.author	Lohinai Zoltán
dc.contributor.author	Klikovits Thomas
dc.contributor.author	Moldvay Judit
dc.contributor.author	Ostoros Gyula
dc.contributor.author	Rásó Erzsébet
dc.contributor.author	Tímár József
dc.contributor.author	Fábián Katalin
dc.contributor.author	Kovalszky Ilona
dc.contributor.author	Kenessey István
dc.contributor.author	Aigner C
dc.contributor.author	Rényi-Vámos Ferenc István
dc.contributor.author	Klepetko W
dc.contributor.author	Döme Balázs
dc.contributor.author	Hegedűs Balázs
dc.date.accessioned	2017-01-05T14:42:58Z
dc.date.available	2017-01-05T14:42:58Z
dc.date.issued	2017
dc.identifier.citation	pagination=39721, pages 8; journalVolume=7; journalTitle=SCIENTIFIC REPORTS;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/3995
dc.identifier.uri	doi:10.1038/srep39721
dc.relation.ispartof	urn:issn:2045-2322
dc.title	KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS-mutation and bone metastasis
dc.type	Journal Article
dc.date.updated	2017-01-05T11:57:18Z
dc.language.rfc3066	en
dc.identifier.mtmt	3152604
dc.contributor.department	SE/AOK/I/IISZPI/MTA-SE Molekuláris Onkológia Kutatócsopor
dc.contributor.department	SE/AOK/I/II. Sz. Patológiai Intézet
dc.contributor.department	SE/AOK/I/I. Sz. Patológiai és Kísérleti Rákkutató Intézet
dc.contributor.department	SE/AOK/K/Pulmonológiai Klinika
dc.contributor.department	SE/AOK/K/Mellkassebészeti Klinika
dc.contributor.institution	Semmelweis Egyetem